Fresh Tracks Therapeutics, Inc. engages in the development of prescription therapeutics for the treatment of skin diseases. Its pipeline consists of new molecular entities targeting the treatment of the following indications: hyperhidrosis, allergic contact dermatitis, androgenic alopecia, cutaneous t-cell lymphoma and psoriasis. The company was founded by Reginald L. Hardy and Andrew D. Sklawer in 2009 and is headquartered in Boulder, CO.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4
Frequently Asked Questions
What is Market Cap of Fresh Tracks Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Fresh Tracks Therapeutics Inc market cap is $5.44M.
What is the 52-week high for Fresh Tracks Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Fresh Tracks Therapeutics Inc 52 week high is $1.10 as of September 12, 2025.
What is the 52-week low for Fresh Tracks Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Fresh Tracks Therapeutics Inc 52 week low is $0.4495 as of September 12, 2025.
What is Fresh Tracks Therapeutics Inc stock price today?
Fresh Tracks Therapeutics Inc stock price today is $0.9102.
What was Fresh Tracks Therapeutics Inc stock price yesterday?
Fresh Tracks Therapeutics Inc stock price yesterday was $0.9101.
What is the PE ratio of Fresh Tracks Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Fresh Tracks Therapeutics Inc’s P/E ratio is -0.65.
What is the Price-to-Book ratio of Fresh Tracks Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Fresh Tracks Therapeutics Inc P/B ratio is 0.5475.
What is Fresh Tracks Therapeutics Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Fresh Tracks Therapeutics Inc's EBITDA is 0.90.
What is the 50-day moving average of Fresh Tracks Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Fresh Tracks Therapeutics Inc 50-day moving average is $0.9126.
How many employess does Fresh Tracks Therapeutics Inc has?